Fatty Liver Disease in Nordic Countries

NCT04340817 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 634

Last updated 2020-04-13

No results posted yet for this study

Summary

A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

DIAGNOSTIC_TEST

Proteomics

Mass-spectometry proteomics

DIAGNOSTIC_TEST

Transcriptomics

Next generation sequencing

GENETIC

Genomics

Targeted genetics

Sponsors & Collaborators

  • Copenhagen University Hospital, Hvidovre

    lead OTHER

Principal Investigators

  • Lise L Gluud, MD · Copenhagen University Hospital, Hvidovre, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2025-09-01
Completion
2026-11-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04340817 on ClinicalTrials.gov